ID: ALA4568483

Max Phase: Preclinical

Molecular Formula: C19H17FN4O2

Molecular Weight: 352.37

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COCn1cc2c(n1)C(=O)N(C)Cc1ccc(-c3ccc(F)cn3)cc1-2

Standard InChI:  InChI=1S/C19H17FN4O2/c1-23-9-13-4-3-12(17-6-5-14(20)8-21-17)7-15(13)16-10-24(11-26-2)22-18(16)19(23)25/h3-8,10H,9,11H2,1-2H3

Standard InChI Key:  JTMJCOYOVJRRNF-UHFFFAOYSA-N

Associated Targets(Human)

Metabotropic glutamate receptor 3 732 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 352.37Molecular Weight (Monoisotopic): 352.1336AlogP: 2.94#Rotatable Bonds: 3
Polar Surface Area: 60.25Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 1.82CX LogP: 2.50CX LogD: 2.50
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.73Np Likeness Score: -0.92

References

1. Kargbo RB..  (2019)  Allosteric mGluR3 Modulators for the Treatment of Psychiatric Disorders.,  10  (2): [PMID:30783491] [10.1021/acsmedchemlett.8b00619]

Source